Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure

Mostrar otras versiones (1)

BACKGROUND: Estimates of seroprevalence to SARS-CoV-2 vary widely and may influence vaccination response. We ascertained IgG levels across a single US metropolitan site, Chicago, from June 2020 through December 2020. METHODS: Participants (n = 7935) were recruited through electronic advertising and...

Descripción completa

Detalles Bibliográficos
Autores principales: Demonbreun, Alexis R., McDade, Thomas W., Pesce, Lorenzo, Vaught, Lauren A., Reiser, Nina L., Bogdanovic, Elena, Velez, Matthew P., Hsieh, Ryan R., Simons, Lacy M., Saber, Rana, Ryan, Daniel T., Ison, Michael G., Hultquist, Judd F., Wilkins, John T., D’Aquila, Richard T., Mustanski, Brian, McNally, Elizabeth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262291/
https://www.ncbi.nlm.nih.gov/pubmed/33755598
http://dx.doi.org/10.1172/jci.insight.146148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262291/
https://www.ncbi.nlm.nih.gov/pubmed/33755598
http://dx.doi.org/10.1172/jci.insight.146148

Ejemplares similares